WallStreetCN Morning Briefing | November 13, 2026
Metrics metrics-v2.1 · Experimental; not used for ranking · Method
What happened
Reported factUS major stock indices all closed lower; NVIDIA fell as much as 14% intraday and closed down over 4%, while rival AMD rose nearly 6%. Trump stated the US does not need a deal with Iran, prompting intr
The text and links above come from the source outlets. The transmission paths and judgement below are VolFlash inference based on those facts, not claims made by the outlets.
Why it matters
VolFlash inferenceTech shock, Middle East flare-up, and Fed hawkishness converge
An analytical judgement, not a statement of fact, and not a price forecast.
Transmission paths
Event → variable → asset class → assetNo transmission path is available for this event.
Affected assets
| Asset | Link | Bias | Rationale |
|---|---|---|---|
| NvidiaNVDASTOCK | Direct | 🔒 Members only | 🔒 Members only |
| WTI Crude Oil FuturesCL=FFUTURE | Indirect | 🔒 Members only | 🔒 Members only |
Link type shows how directly the asset connects to the event. Direction is a judgement; it stays Unclear when evidence is insufficient.
Watch next
The watchlist is members-only — knowing which indicators to track is half the value. Unlock full analysis
Invalidation conditions
The invalidation conditions are members-only — knowing what would prove this wrong matters as much as the call itself. Unlock full analysis
Market reaction
Unavailable — no verified market reaction data.
VolFlash captures a market snapshot only within 5 minutes of a scheduled data release, with window, baseline and source attached. This event has no such capture, so there is no verified before/after price data — and we do not infer one.
Related events
Same topic / categoryThe 8 highest-severity events of the past 24h, with our read and source links. Unsubscribe anytime.
Published 2026-11-12 23:15:53 · Source wallstcn · Automatically aggregated and analysed — verify against the original source.
Public information plus VolFlash reasoning. Not investment advice; no price targets.